613 related articles for article (PubMed ID: 3527659)
1. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Ward A; Chaffman MO; Sorkin EM
Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
[TBL] [Abstract][Full Text] [Related]
2. [Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
[TBL] [Abstract][Full Text] [Related]
3. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
[TBL] [Abstract][Full Text] [Related]
4. Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome.
Bismuth C; de Rohan-Chabot P; Goulon M; Raphael JC
Acta Neurol Scand Suppl; 1984; 100():193-8. PubMed ID: 6148831
[TBL] [Abstract][Full Text] [Related]
5. Fatal thermal injury.
Denborough M
Med J Aust; 1989 May; 150(10):608. PubMed ID: 2716576
[No Abstract] [Full Text] [Related]
6. [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Spiess-Kiefer C; Hippius H
Fortschr Neurol Psychiatr; 1986 May; 54(5):158-70. PubMed ID: 2426164
[TBL] [Abstract][Full Text] [Related]
7. Dantrolene dose response in awake man: implications for management of malignant hyperthermia.
Flewellen EH; Nelson TE; Jones WP; Arens JF; Wagner DL
Anesthesiology; 1983 Oct; 59(4):275-80. PubMed ID: 6614536
[No Abstract] [Full Text] [Related]
8. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
Pinder RM; Brogden RN; Speight TM; Avery GS
Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
[TBL] [Abstract][Full Text] [Related]
9. Dantrolene.
Britt BA
Can Anaesth Soc J; 1984 Jan; 31(1):61-75. PubMed ID: 6362802
[No Abstract] [Full Text] [Related]
10. Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.
Britt BA; Scott E; Frodis W; Clements MJ; Endrenyi L
Can Anaesth Soc J; 1984 Mar; 31(2):130-54. PubMed ID: 6704779
[TBL] [Abstract][Full Text] [Related]
11. [Sodium dantrolene].
Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome.
Larner AJ
Br J Psychiatry; 1992 Jun; 160():868. PubMed ID: 1617375
[No Abstract] [Full Text] [Related]
13. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
Schulte-Sasse U; Komar K; Eberlein HJ
Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
[TBL] [Abstract][Full Text] [Related]
14. Dantrolene.
Hetherington N
Aust Nurses J; 1992 Mar; 21(8):28-9. PubMed ID: 1605782
[No Abstract] [Full Text] [Related]
15. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
16. [New findings and experiences in the field of malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519
[TBL] [Abstract][Full Text] [Related]
17. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
Friesen CM; Brodsky JB; Dillingham MF
Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
[TBL] [Abstract][Full Text] [Related]
18. The neuroleptic malignant syndrome--a review.
Gibb WR; Lees AJ
Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant.
Heiman-Patterson TD
Med Clin North Am; 1993 Mar; 77(2):477-92. PubMed ID: 8095087
[TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia: current perspectives.
Felice-Johnson J; Sudds T; Bennett G
Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
